Business
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal
CARLSBAD, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the publication of a new retrospective cohort study in Global Spine Journal demonstrating that 3D preoperative planning combined with patient-specific, anatomically designed interbody implants significantly reduces mechanical complication–related reoperations in complex adult spinal deformity (ASD) surgery. The study compared 2-year revision rates among ASD patients re
About this update from Carlsmed, Inc.
[{"type":"image","alt":"Carlsmed","displaySize":"","headline":null,"caption":"Carlsmed","className":"","disableSlideshowImg":false,"size":{"original":{"width":282,"height":62,"url":"https://media.zenfs.com/en/globenewswire.com/cccd860298c64d0a18c1d7b3706250f7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hS_gs.MQTCoePNI_FWsiww--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkyO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/cccd860298c64d0a18c1d7b3706250f7","width":282,"height":62}},"lazy":false},{"type":"text","content":"CARLSBAD, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the publication of a new retrospective cohort study in Global Spine Journal demonstrating that 3D preoperative planning combined with patient-specific, anatomically designed interbody implants significantly reduces mechanical complication–related reoperations in complex adult spinal deformity (ASD) surgery.","length":442,"tagName":"p"},{"type":"text","content":"The study compared 2-year revision rates among ASD patients receiving Carlsmed’s aprevo® personalized interbody implants with revision data from a similar patient cohort receiving conventional stock implants. The comparator cohort was drawn from the multicenter dataset of the International Spine Study Group, which is comprised of senior spine surgeons dedicated to advancing the treatment of adult spinal deformity. Patients treated with aprevo® experienced significantly fewer revisions due to mechanical complications, showing a revision rate of 4.3% (n=115) compared with 16.6% (n=997) using stock devices (p<0.001), representing a 74% relative reduction.","length":663,"tagName":"p"},{"type":"text","content":"“In complex deformity cases where alignment accuracy is critical, translating preoperative goals into postoperative outcomes remains a persistent challenge,” said Justin Smith, MD, PhD, Department of Neurosurgery, University of Virginia and the article’s lead author. “When paired with 3D preoperative planning, patient-specific interbody implants can facilitate a more harmonious and precise restoration of distal lumbar lordosis, which has been shown to decrease the risk of developing proximal junctional kyphosis, a significant and potentially devastating mechanical complication in ASD surgery.”","length":600,"tagName":"p"},{"type":"text","c...